全文获取类型
收费全文 | 24553篇 |
免费 | 2525篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 225篇 |
儿科学 | 692篇 |
妇产科学 | 587篇 |
基础医学 | 3363篇 |
口腔科学 | 603篇 |
临床医学 | 2901篇 |
内科学 | 5091篇 |
皮肤病学 | 351篇 |
神经病学 | 2379篇 |
特种医学 | 771篇 |
外科学 | 3213篇 |
综合类 | 585篇 |
一般理论 | 15篇 |
预防医学 | 2554篇 |
眼科学 | 455篇 |
药学 | 2126篇 |
1篇 | |
中国医学 | 29篇 |
肿瘤学 | 1176篇 |
出版年
2021年 | 360篇 |
2020年 | 202篇 |
2019年 | 351篇 |
2018年 | 407篇 |
2017年 | 328篇 |
2016年 | 313篇 |
2015年 | 371篇 |
2014年 | 516篇 |
2013年 | 769篇 |
2012年 | 1117篇 |
2011年 | 1157篇 |
2010年 | 666篇 |
2009年 | 555篇 |
2008年 | 999篇 |
2007年 | 1176篇 |
2006年 | 1088篇 |
2005年 | 1129篇 |
2004年 | 999篇 |
2003年 | 1065篇 |
2002年 | 955篇 |
2001年 | 690篇 |
2000年 | 693篇 |
1999年 | 597篇 |
1998年 | 283篇 |
1997年 | 225篇 |
1996年 | 212篇 |
1995年 | 251篇 |
1994年 | 228篇 |
1992年 | 521篇 |
1991年 | 483篇 |
1990年 | 462篇 |
1989年 | 458篇 |
1988年 | 415篇 |
1987年 | 420篇 |
1986年 | 371篇 |
1985年 | 436篇 |
1984年 | 375篇 |
1983年 | 296篇 |
1982年 | 285篇 |
1981年 | 234篇 |
1980年 | 238篇 |
1979年 | 345篇 |
1978年 | 294篇 |
1977年 | 208篇 |
1976年 | 242篇 |
1975年 | 212篇 |
1974年 | 272篇 |
1973年 | 284篇 |
1972年 | 232篇 |
1971年 | 213篇 |
排序方式: 共有10000条查询结果,搜索用时 14 毫秒
141.
142.
Y E Shen W G Sorenson D M Lewis S A Olenchock 《Biomedical and environmental sciences : BES》1990,3(3):353-363
Fourteen samples of settled dust from two factories processing rice and wheat straw near Shanghai, China, were examined by dilution plating for total bacteria, gram-negative bacteria, thermophilic actinomycetes, and fungi. They were also examined for aflatoxin, endotoxin, and potential to stimulate production of human interleukin 1 beta (IL-1 beta) and to consume complement. The concentrations of total microorganisms were consistently greater than 10(7) CFU/g and ranged from 10(7) to 10(9) CFU/g. In general, the level of microbial contamination was greater in the hay dust samples than in the rice dust samples, with bacteria being the most numerous microorganisms observed followed by molds, thermophilic actinomycetes, and yeasts. The predominant fungi were species of Aspergillus, Cladosporium, Penicillium, Trichosporon, and Cryptococcus. No significant levels of aflatoxin were observed and the isolates of A. flavus examined lack significant aflatoxigenic potential. The levels of microorganisms in these samples, the types of organisms found, and the inflammatory mediators such as endotoxin suggest that workers exposed to these dusts may be at risk for respiratory illness. 相似文献
143.
144.
145.
146.
E F Ellerbeck J A Lewis D Nalin K Gershman W J Miller M E Armstrong J P Davide A E Rhoad B McGuire G Calandra 《Vaccine》1992,10(10):668-672
To determine the safety and immunogenicity of an inactivated hepatitis A vaccine, 56 healthy adult volunteers were randomly assigned to receive an intramuscular injection of 6.3, 12.5 or 25 ng of inactivated hepatitis A vaccine or placebo at 0, 2 or 4, and 24 weeks. Adverse reactions occurred with similar frequency in vaccine and placebo recipients and consisted primarily of pain or tenderness at the injection site. By 4 weeks after a single 6.3, 12.5 or 25 ng injection, seven, nine and ten out of ten vaccinees, respectively, had antibody detectable by a HAV AB assay modified to increase its sensitivity tenfold. All vaccinees had antibodies detectable by this assay within 2 weeks of their second inoculation. Geometric mean antibody levels increased with higher doses of vaccine (p = 0.05). Neutralizing antibody was detected within 4 weeks of a single inoculation in all vaccinees. Neutralizing antibody was detected after the third inoculation at dilutions of greater than or equal to 1:2048 in all 12.5 and 25 ng vaccinees. All 19 vaccinees tested at 24 months still had HAV antibodies detectable by a modified HAV AB assay. This inactivated hepatitis A vaccine appears to be well tolerated and immunogenic at doses of 6.3-25 ng. The choice of dose and vaccination schedule may depend on the rapidity with which seroconversion is desired. 相似文献
147.
Giovanni Manfredi Tuan Vu Eduardo Bonilla Eric A. Schon Salvatore DiMauro Enrica Arnaudo Lee Zhang Lewis P. Rowland Michio Hirano 《Annals of neurology》1997,42(2):180-188
We identified large-scale heteroplasmic mitochondrial DNA (mtDNA) rearrangements in a 50–year-old woman with an adult-onset progressive myopathy. The predominant mtDNA abnormality was a 21.2–kb duplicated molecule. In addition, a small population of the corresponding partially deleted 4.6–kb molecule was detected. Skeletal muscle histology revealed fibers that were negative for cytochrome c oxidase (COX) activity and had reduced mtDNA-encoded COX subunits. By single-fiber polymerase chain reaction analysis, COX-negative fibers contained a low number of wild-type or duplicated mtDNA molecules (ie, nondeleted). In situ hybridization demonstrated that the abnormal fibers contained increased amounts of mtDNA compared with normal fibers and that most of the genomes were deleted. We concluded that deleted mtDNA molecules were primarily responsible for the phenotype in this patient. 相似文献
148.
Schools of public health have been cautioned about producing graduates and research that were disconnected from public interest. Although institutions may implement a variety of strategies to rectify the situation, institutional structural and cultural barriers impede progress. Public health practice coordinators in accredited schools of public health were surveyed to describe the presence of structural and cultural barriers to academic public health practice using the Stevens model. Administrative leadership and faculty reward systems are described as critical to advance academic public health practice. 相似文献
149.
150.
Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma 总被引:3,自引:1,他引:2
下载免费PDF全文
![点击此处可从《Thorax》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A. F. Wisniewski S. A. Lewis D. J. Green W. Maslanka H. Burrell A. E. Tattersfield 《Thorax》1997,52(10):853-860
BACKGROUND: Bone mineral density has been reduced in patients with asthma taking inhaled corticosteroids in some cross sectional studies and this could be important if treatment is continued for several decades. The possibility of confounding by age, menopausal status, physical activity and, especially, past oral steroid use has not been excluded in most studies. The present study was designed to assess the magnitude of any reduction in bone mineral density in relation to inhaled steroid use after adjusting for these factors. METHODS: Bone mineral density (BMD), vertebral fractures, and markers of bone metabolism (serum osteocalcin, procollagen peptide I, bone-specific alkaline phosphatase, and urinary deoxypyridinoline cross links) were measured in 81 patients with asthma age 20-40 years; 34 patients (19 men) who had never had inhaled or systemic steroids and 47 (19 men) who had taken inhaled steroids for at least five years with limited exposure to systemic steroids in the past. Data relating to past medication use, physical activity, smoking, and other confounding factors were collected by questionnaire. The relation between inhaled steroid dose and duration and BMD was assessed by linear regression analysis, accounting for potential confounders including weight, exercise, and oral steroid use. RESULTS: The 47 patients taking an inhaled steroid had a mean current dose of 620 micrograms/day (range 100-3000 micrograms), a mean duration of use of 7.8 years, and had had a mean of 0.85 courses of prednisolone in the past. There was no significant difference in mean BMD values between those who were and those who were not on inhaled steroids in men or women. However, on multivariate analysis, cumulative inhaled steroid dose was associated with a reduction in posterior-anterior (P-A) and lateral lumbar spine bone mineral density in women, equivalent to a 0.11 standard deviation reduction in bone density per 1000 micrograms/day inhaled steroid per year after adjustment for potential confounding factors (95% CI for P-A spine 0.01 to 0.22; for lateral spine 0.02 to 0.21). Previous oral steroid use was not an important confounding factor in these patients. Inhaled steroid use was not related to BMD at the wrist or hip in women or at any skeletal site in men. Women taking an inhaled steroid had lower levels of serum osteocalcin than those not taking them, although this was not dose related. Inhaled steroid use was not associated with differences in other markers of bone metabolism in men or women or with the presence of vertebral fractures. CONCLUSIONS: Although an effect of confounding factors cannot be excluded entirely in a cross sectional study, our findings are in keeping with an effect of inhaled steroid therapy in reducing bone density in the spine in women and provide an estimate of the magnitude of this effect.
相似文献
相似文献